‹ All Posts
Koustubh

13th Aug 2025 · SEBI-Registered Analyst

MTARTECH
's finally hitting its stride after years of promising big and delivering small.

A 144% profit surge to ₹10.8 crores with margins expanding from 12.9% to 18.1% shows they're not just growing revenue but actually making money on it. The order book targeting ₹1,500-2,000 crores with ₹800 crores in execution and ₹1,000 crores in nuclear orders over the next 3-6 months sounds impressive for a company this size. What's encouraging is their diversified mix across aerospace, clean energy, and nuclear - these are all long-cycle, high-value sectors where relationships and technical expertise matter more than just price. Once you're in with ISRO or nuclear power companies, the switching costs are massive. But here's my concern:

MTARTECH
has a history of big announcements that take forever to convert into actual revenue. Aerospace and nuclear projects are notorious for delays, cost overruns, and changing specifications. They're planning aggressive capex expansion while trying to maintain these improved margins, which is always tricky. The 25% revenue growth target for this fiscal is ambitious but achievable if their order pipeline is real. The key is whether they can execute these large contracts without the usual project delays that have plagued them before. At current valuations, investors are clearly betting on flawless execution of a much larger business.

#FundamentalViews#WatchOutFor#StockInNews#EquityResearch#TrendingSectors
Screenshot 2025-08-13 at 9.53.24 AM.png
426 likes·33 comments